Compare ZGN & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZGN | NVST |
|---|---|---|
| Founded | 1910 | 2018 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.2B |
| IPO Year | 2021 | 2019 |
| Metric | ZGN | NVST |
|---|---|---|
| Price | $14.93 | $26.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $11.28 | ★ $26.46 |
| AVG Volume (30 Days) | 1.2M | ★ 2.4M |
| Earning Date | 03-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $2,566,500,000.00 |
| Revenue This Year | $5.17 | $6.67 |
| Revenue Next Year | $7.89 | $3.55 |
| P/E Ratio | ★ $25.94 | $114.48 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.61 | $18.77 |
| 52 Week High | $15.44 | $30.42 |
| Indicator | ZGN | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 62.94 | 53.71 |
| Support Level | $9.89 | $24.21 |
| Resistance Level | $15.44 | $27.00 |
| Average True Range (ATR) | 0.60 | 0.76 |
| MACD | 0.12 | -0.10 |
| Stochastic Oscillator | 99.48 | 60.00 |
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of revenue from the Zegna segment.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.